Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Use of antiviral drugs to reduce COVID-19 transmission.
Tuberculosis-associated IFN-I induces Siglec-1 on tunneling nanotubes and favors HIV-1 spread in macrophages.
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing.
New emerging targets in cancer immunotherapy: the role of neoantigens.
Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema.
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV.
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80.
A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction.
Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure.
HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design.